10-Q 1 ammj10q052615.htm

 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016.

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______.

 

Commission File Number 000-26108

AMERICAN CANNABIS COMPANY, INC.

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)
94-2901715
(I.R.S. Employer
Identification No.)

5690 Logan St. Unit A
Denver, Colorado
(Address of principal executive offices)

80216
(Zip Code)

 

(303) 974-4770
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ] Accelerated filer  [ ] Non-accelerated filer 
 (Do not check if a
smaller reporting company)
[ ] Smaller reporting company  [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

On May 17, 2015, 45,642,064 shares of common stock were outstanding.   

 TABLE OF CONTENTS

 

PART I. FINANCIAL INFORMATION Page
Item 1. FINANCIAL STATEMENTS (Unaudited): 1
CONDENSED CONSOLIDATED BALANCE SHEETS AS OF MARCH 31, 2016 AND DECEMBER 31, 2015 1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2016 AND THE THREE MONTHS ENDED MARCH 31, 2015 2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED MARCH 31, 2016 AND MARCH 31, 2015 3
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 4
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 14
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 18
Item 4. CONTROLS AND PROCEDURES 18
PART II. OTHER INFORMATION 20
Item 1. LEGAL PROCEEDINGS 20
Item 1A. RISK FACTORS 20
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 20
Item 3. DEFAULTS UPON SENIOR SECURITIES 20
Item 5. OTHER INFORMATION 20
Item 6. EXHIBITS
SIGNATURES 21

PART I—FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS


AMERICAN CANNABIS COMPANY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 

 

    March 31,   December 31,
    2016   2015
ASSETS
Current assets
Cash and cash equivalents $ 277,453 $ 555,780
Accounts receivable, net 27,267 48,285
Deposits 9,345 9,345
Inventory 101,395 67,435
Prepaid expenses and other current assets 42,821 32,117
Total current assets 458,281 712,962
Property and equipment, net 14,039 13,448
Other Assets 4,500 4,500
TOTAL ASSETS $ 476,820 $ 730,910
LIABILITIES AND STOCKHOLDER’S EQUITY
Current liabilities
Accounts payable $ 54,778 $ 218,334
Advances from clients 148,084 220,966
Convertible note, net of discount 69,250 60,252
Accrued and other current liabilities 72,846 93,468
Total current liabilities 344,958 593,020
Total liabilities 344,958 593,020
Commitments and contingencies
Stockholders’ equity
Preferred stock, $0.01 par value, 5,000,000 shares authorized; no shares issued and outstanding —   —  
Common stock, $0.00001 par value, 100,000,000 shares authorized; 45,642,064 and
44,808,731 issued and outstanding at March 31, 2016 and December 31, 2015 respectively 456 448
Additional paid-in capital 4,276,229 4,268,708
Retained deficit (4,144,823 ) (4,131,266 )
Total stockholders’ equity 131,862 137,890
Total liabilities and stockholders’ equity $ 476,820 $ 730,910

The accompanying notes are an integral part of these financial statements.

 AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)
 

 

    Three Months   Three Months
    Ended March 31,   Ended March 31,
    2016   2015
Revenues
Consulting services $ 247,610 $ 195,570
Products and equipment 292,794 248,097
Total revenues 540,404 443,667
Costs of revenues
Cost of consulting services 48,552 100,892
Cost of products and equipment 235,009 225,651
Total costs of revenues 283,531 326,543
Gross profit 256,873 117,124
Operating expenses
General and administrative expenses 223,487 79,083
Selling and marketing expenses 20,815 94,305
Research and development expenses —   30,372
Investor Relations 17,175 131,416
Total operating expenses 261,477 335,176
Income (loss) from operations (4,604 ) (218,052 )
Other income (expense)
Interest expense, net (8,953 ) (8,786 )
Total other income (expense) (8,953 ) (8,786 )
Net income (loss) before income taxes (13,557 ) (226,838 )
Income tax expense (benefit) —   —  
Net income (loss) $ (13,557 ) $ (226,838 )
Basic and diluted net income (loss) per common share * $ (0.00 ) $ (0.01 )
Weighted average basic and diluted common shares outstanding 44,881,991 44,782,078
* Denotes a loss of less than ($0.01).

The report on the financial statements and accompanying notes are an integral part of these financial statements.

AMERICAN CANNABIS COMPANY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

Three Months Three Months
Ended March 31, Ended March 31,
2016 2015
Cash flows from operating activities:
Net loss $ (13,557 ) $ (226,838 )
Adjustments to reconcile net income (loss) to net cash
provided by (used in) operating activities:
Depreciation 1,214 716
Amortization of discount on convertible note payable 8,998 8,803
Stock-based compensation to employees 7,529 43,271
Stock-based compensation to service providers 1,100 63,841
Changes in operating assets and liabilities:
Accounts receivable 21,018 (48,542 )
Deposits —   116,929
Inventory (33,960 ) (146,225 )
Prepaid expenses and other current assets (10,704 ) (4,957 )
Advances from Clients (72,883 ) (148,528 )
Accrued liabilities and other current liabilities (21,722 ) 72,312
Accounts payable (163,555 ) 182,026
Net cash used in operating activities (276,522 ) (87,192 )
Cash flows from investing activities:
Purchases of property and equipment (1,805 ) (11,250 )
Net cash used in investing activities (1,805 ) (11,250 )
Cash flows from financing activities:
Proceeds from issuance of common stock —   250,000
Net cash provided by financing activities —   250,000
Net increase (decrease) in cash and cash equivalents (278,327 ) 151,558
Cash and cash equivalents at beginning of period 555,780 165,213
Cash and cash equivalents at end of period $ 277,453 $ 316,771
Supplemental disclosure of cash flow information:
Cash paid for (received from) interest $ —   $ (17 )
Cash paid for (received from) income taxes, net $ —   $ —  

The accompanying notes are an integral part of these financial statements. 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2016 and 2015
(Unaudited)

 

Note 1. Description of the Business

 

American Cannabis Company, Inc. and its subsidiary company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. The Company provides advisory and consulting services specific to this industry, designs industry-specific products and facilities, and manages a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. American Cannabis Company, Inc. is a publicly listed company quoted on the OTCQB under the symbol “AMMJ”.

American Cannabis Company, Inc. was incorporated in the State of Delaware on September 24, 2001 under the name Naturewell, Inc. to develop and market clinical diagnostic products using immunology and molecular biologic technologies.

On March 13, 2013, Naturewell, Inc. completed a merger transaction whereby it acquired 100% of the issued and outstanding share capital of Brazil Interactive Media, Inc. (“BIMI”), which operated as a Brazilian interactive television company and television production company through its wholly owned Brazilian subsidiary company EsoTV Brasil Promoção Publicidade Licenciamento e Comércio Ltda. (“EsoTV”). Naturewell’s Articles of Incorporation were amended to reflect a new name: Brazil Interactive Media, Inc.

On May 15, 2014, BIMI entered into a merger agreement (“the Merger Agreement”) to acquire 100% of the issued and outstanding shares of American Cannabis Consulting while simultaneously disposing of 100% of the issued share capital EsoTV (“the Separation Agreement”). Both the merger with American Cannabis Consulting and disposal of EsoTV were completed on September 29, 2014. BIMI subsequently amended its Articles of Incorporation to change its name to American Cannabis Company, Inc.. On October 10, 2014, American Cannabis Company, Inc changed its stock symbol from BIMI to AMMJ.

The foregoing descriptions of the Merger Agreement and Separation Agreement do not purport to be complete and are qualified in their entirety by the terms of such agreements, which are filed as exhibits to the Current Report on Form 8-K filed by the Company with the U.S. Securities and Exchange Commission (“SEC”) on October 3, 2014.

Immediately following the completion of the Merger Agreement, former shareholders of American Cannabis Consulting owned 31,710,628 shares of American Cannabis Company, Inc.’s common stock representing 78.44% of American Cannabis Company, Inc.’s issued and outstanding share capital. Accordingly, American Cannabis Consulting was deemed to have been the accounting acquirer in a Reverse Merger which resulted in a recapitalization of the Company. Consequently, the Company’s condensed consolidated financial statements reflect the results of American Cannabis Consulting since Inception (March 5, 2013) and of American Cannabis Company, Inc. (formerly BIMI) since September 29, 2014.

Note 2. Summary of Significant Accounting Policies

 

Basis of Accounting

The financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). The Company has elected a fiscal year ending on December 31. Certain balance sheet reclassifications have been made to prior period balances to reflect the current period’s presentation format; such reclassifications had no impact on the Company’s consolidated statements of operations or consolidated statements of cash flows and had no material impact on the Company’s consolidated balance sheets.

 

Use of Estimates in Financial Reporting

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are deemed to be necessary. Significant estimates made in the accompanying financial statements include but are not limited to following: those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, contingencies and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company's financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the financial statements.

 

Unaudited Interim Financial Statements

The accompanying unaudited financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X.  Accordingly, the financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.

  

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.

Accounts Receivable

Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of March 31, 2016 and December 31, 2015, the Company’s allowance for doubtful accounts was $8,418 and $8,418, respectively. The Company did not record bad debt expense during the three months ended March 31, 2016 or during the three months ended March 31, 2015.

 

Deposits

Deposits is comprised of advance payments made to third parties, primarily for inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see “Costs of Revenues” below).

 

Inventory

Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of March 31, 2016 and December 31, 2015, market values of all of the Company’s inventory were greater than cost, and accordingly, no such valuation allowances were recognized.

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

 

Significant Clients and Customers

For the three months ended March 31, 2016, five customers individually accounted for $514,824 of the Company’s total revenues; these customers accounted for approximately 95% of the Company’s total revenues for the period. For the three months ended March 31, 2015, three clients individually accounted for 10% or more of the Company’s revenues, and in aggregate, they comprised approximately 79% of the Company’s total revenues for the period.

Property and Equipment, net

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred and depreciation is consummated once the underlying asset is placed into service. Property and equipment is reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of March 31, 2016.

Accounting for the Impairment of Long-Lived Assets

The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of March 31, 2016 or December 31, 2015.

Beneficial Conversion Feature

If the conversion features of conventional convertible debt provides for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature (“BCF”).  A BCF is recorded by the Company as a debt discount pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ACF”) Topic 470-20 Debt with Conversion and Other Options. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and the Company amortizes the discount to interest expense, over the life of the debt using the effective interest method. 

Revenue Recognition

Revenue is recognized in accordance with FASB ASC Topic 605, Revenue Recognition. The Company recognizes revenue when persuasive evidence of an arrangement exists, the related services are rendered or delivery has occurred, the price is fixed or determinable and collectability is reasonably assured.

The Company generates revenues from professional services consulting agreements. These arrangements are generally entered into on a time basis, for a fixed-fee or on a contingent fee basis. Generally, a prepayment or retainer is required prior to performing services.

Revenues from time-based engagements are recognized as the hours are incurred by the Company.

Revenues from fixed-fee engagements are recognized under the completed or proportional performance methods. Management reviews arrangement to determine whether or not the fixed-fee is for a final deliverable or act which is significant to the arrangement as a whole. If it is, revenue is recognized under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered. Revenue recognized under the proportional performance method is recognized as services are performed. Under this method, the Company estimates the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable in order to determine the amount of revenue to be recognized. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. During the three month periods ended March 31, 2016 and March 31, 2015, no such losses have occurred. The Company believes if an engagement terminates prior to completion it can recover the costs incurred related to the services provided.

The Company has some arrangements for which revenues are contingent upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

The Company’s arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”). Revenues are recognized in accordance with our accounting policies for the elements as described above. The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price. While assigning values and identifying separate elements requires judgment, generally selling prices of the separate elements are readily identifiable as the Company also sells those elements individually outside of a multiple services engagement. Contracts with multiple elements are typically fixed-fee or on time basis. Arrangements are typically terminable by either party upon sufficient notice and do not include provisions for refunds relating to services provided.

Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenue in the accompanying balance sheet. Revenues recognized for services performed, but not yet billed to clients are recorded as unbilled services.

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses are included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are presented in the statement of operations on a net basis.

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained, the price is fixed and determinable, the product is shipped, title has transferred and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with origin terms. For any shipments with destination terms, the Company defers revenue until delivery to the customer. During the three months ended March 31, 2016 and March 31, 2015, sales returns were not significant and as such, no sales return allowance had been recorded as of March 31, 2016 and December 31, 2015.

Costs of Revenues

The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

Advertising and Promotion Costs

Selling and Marketing costs are included as a component of selling and marketing expense and are expensed as incurred. During the three months ended March 31, 2016 and March 31, 2015, these costs were $20,815 and $94,305, respectively.

 

Shipping and Handling Costs

For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.

Stock-Based Compensation

Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. The Company recognizes related compensation costs on a straight-line basis over the requisite vesting period of the award. During the three months ended March 31, 2016, the Company had employee stock-based compensation expense of $7,529. Compensation expense for warrants and options is based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model. During the three months ended March 31, 2016, there was no compensation expense for warrants or stock options.

 

Income Taxes

The Company’s corporate status changed from an S-Corporation, which it had been since inception, to a C-Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S-Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S-Corporation’s taxable income. Accordingly, we were not subject to income taxes for the three months ended March 31, 2014. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized.  For the three months ended March 31, 2016, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of March 31, 2016 and December 31, 2015, we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.

Net Income (Loss) Per Common Share

The Company reports net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

  

Related Party Transactions

The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which statements of operation are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which statements of operations are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

See Note 11. Related Party Transactions for associated disclosures.

 

Recent Accounting Pronouncements

 

The Company has reviewed all the recently issued, but not yet effective, accounting pronouncements and it does not believe any of these pronouncements will have a material impact on the Company.

 

Note 3. Accounts Receivable, net

 

Accounts receivable, net, was comprised of the following as of March 31, 2016 and December 31, 2015:

March 31, 2016 December 31, 2015
(Unaudited) (Audited)
Gross accounts receivable $ 35,686 $ 56,704
Less: allowance for doubtful accounts (8,419 ) (8,419 )
Accounts receivable, net $ 27,267 $ 48,285

The Company had no bad debt expense during the three months ended March 31, 2016 and March 31, 2015.

Note 4. Deposits

 

Deposits was comprised of the following as of March 31, 2016 and December 31, 2015:

 

March 31, 2016 December 31, 2015
(Unaudited) (Audited)
Inventory deposits $ 9,345 $ 9,345
Operating lease deposits 4,500 4,500
Deposits $ 13,845 $ 13,845

Inventory deposits reflect down payments made to suppliers or manufacturers under inventory purchase agreements.

 

Note 5. Inventory

 

Inventory as of March 31, 2016 and December 31, 2015 of $101,395 and $67,435, respectively, was fully comprised of finished goods.

 

Note 6. Prepaid expenses and other current assets

 

Prepaid expenses and other current assets was comprised of the following as of March 31, 2016 and December 31, 2015:

 

March 31, 2016 December 31, 2015
(Unaudited) (Audited)
Prepaid expenses 37,556 28,907
Other current assets 5,265 3,210
Prepaid expenses and other current assets $ 42,821 $ 32,117

  

Note 7. Property and Equipment, net

Property and equipment, net, was comprised of the following as of March 31, 2016 and December 31, 2015:

March 31, 2016 December 31, 2015
(Unaudited) (Audited)
Office equipment $ 9,275 $ 7,472
Furniture and fixtures 8,777 8,777
Machinery and equipment 2,337 2,336
Property and equipment, gross 20,389 18,585
Less: accumulated depreciation (6,350 ) (5,137 )
Property and equipment, net $ 14,039 $ 13,448

The Company recorded depreciation expense of $1,214 and $716 during the three months ended March 31, 2016 and March 31, 2015, respectively.

 

Note 8. Notes Payable

As of March 31, 2015, the Company had remaining convertible debentures in the total amount of $71,500. The debentures were originally issued on April 24, 2014, matured on April 24, 2016, paid zero interest, and are convertible until maturity at the holders’ discretion into shares of the Company’s common stock at $0.08 per share. As of April 11th, 2016, the maturity date on this note was renegotiated to April 24th, 2018. On April 12, 2016, the Company received notice of a partial conversion of this note in the amount of $58,000 that was converted into 725,000 shares of common stock at a price of $0.08 per share. On May 6, 2016, the Company received notice for the conversion of the balance of the note in the amount of $13,500 that was converted into 168,750 shares of common stock at a price of $0.08 per share.  Based on this conversion, as of March 31, 2016, the balance of $69,250 is reflected as a current liability.

Note 9. Accrued and Other Current Liabilities

 

Accrued and other current liabilities was comprised of the following at March 31, 2016 and December 31, 2015:

March 31, 2016 December 31, 2015
(Unaudited) (Audited)
Accrued payroll liabilities 22,812 18,185
Accrual for inventory products sold and shipped (in transit) 40,773 64,050
Other accruals 9,261 11,233
Accrued and other current liabilities $ 72,846 $ 93,468

Note 10. Net (Loss) Per Common Share

The following is a reconciliation of weighted common shares outstanding used in the calculation of basic and diluted net income (loss) per common share:

 

Three Months Ended Three Months Ended
March 31, 2016 March 31, 2015
(Unaudited) (Unaudited)
Net income (loss) $ (13,557 ) $ (226,838 )
Weighted average shares used for basic net income (loss) per common share 44,881,991 44,782,078
Incremental diluted shares —   —  
Weighted average shares used for diluted net income (loss) per common share 44,881,991 44,782,078
Net income (loss) per common share:
Basic $ *(0.00 ) $ (0.01 )
Diluted $ *(0.00 ) $ (0.01 )
*Denotes a loss of less than $0.01

  

Note 11. Related Party Transactions

During the three months ended March 31, 2016, the Company incurred $6,000 of expense payable to JDE Development LLC, a company in which Jesus M Quintero, the Company’s Chief Financial Officer, is an owner. During the three months ended March 31, 2015, the Company incurred $13,887 of expense payable to New Era CPAs, an accounting firm in which Antonio Migliarese, the Company’s former Chief Financial Officer, is a partner. This expense is payable in 35,607 shares of the Company’s common stock. As of March 31, 2016, the Company owed Mr. Migliarese 65,607 shares of common stock valued at $32,187. During the three months ended March 31, 2016 and 2015, the Company generated revenue from the sale of products in the amount of $500 and $0, respectively, to a company controlled by a Director, of which the balance of the related accounts receivable as of March 31, 2016 and March 31, 2015 was $4,035 and $0, respectively.

  

Note 12.  Commitments and Contingent Liabilities

On March 1, 2016, the Company retained Brian Johnson as a consultant for an initial term of three months until May 31, 2016, and agreed to pay Mr. Johnson 10,000 shares of its restricted common stock for the three-month term payable on May 31, 2016.

On January 20, 2016, we were named as a defendant in a civil suit entitled: Anthony Baroud vs. Hollister & Blacksmith, Inc., dba American Cannabis Company filed in the Circuit Court of Cook County, Illinois. The lawsuit seeks damages of $100,000 related to an employment contract. The Company filed a motion to compel contractual arbitration that has yet to be ruled on by the Court.

Note 13. Stock-based Compensation

Restricted Shares

From time to time, the Company grants certain employees restricted shares of its common stock to provide further compensation in-lieu of wages and to align the employee’s interests with the interests of its stockholders. Because vesting is based on continued employment, these equity-based incentives are also intended to attract, retain and motivate personnel upon whose judgment, initiative and effort the Company’s success is largely dependent. The Company issued no restricted shares during the period covered by this report.

On March 1, 2016, the Company retained Brian Johnson as a consultant for an initial term of three months until May 31, 2016, and agreed to pay Mr. Johnson 10,000 shares of its restricted common stock per month for the three-month term payable on May 31, 2016. From the date of the grant to March 31, 2016, shares issuable to Mr. Johnson had a value of $1,100.00.

Warrants

 

As of March 31, 2016, fully-vested warrants issued to the Company’s independent board member to purchase up to two hundred and fifty thousand (250,000) shares of common stock at an exercise price of sixty-three cents ($0.63) per share were outstanding, exercisable within five (5) years of the date of issuance on November 19, 2014. The grant date fair value of the warrants, as calculated based on the Black-Scholes valuation model, was $0.59 per share. There were no outstanding unvested warrants or new issuances of warrants during the three months ended March 31, 2016; consequently, no stock-based compensation expense associated with warrant was recorded during the three months ended March 31, 2016.

As of March 31, 2016 and December 31, 2015, as the exercise price per share exceeded the price per share of our common shares, there was no aggregate intrinsic value of outstanding warrants. As of March 31, 2016 and December 31, 2015, the warrants had 3.9 and 3.6 years remaining until expiration, respectively. No warrants were issued or outstanding during or preceding the three months ended March 31, 2016.

Stock Options

In addition to the warrants as described above, the Company’s independent board member shall be eligible to receive options for 400,000 shares of common stock under the Company’s incentive plan, as and when duly approved by the Board of Directors. As these stock options were not granted as of March 31, 2016, no expense in relation to these options was recognized during the three months ended March 31, 2016

Stock Issuable in Compensation for Professional Services

From time to time, the Company enters into agreements whereby a professional service provider will be compensated for services rendered to the Company by shares of common stock in lieu of cash. During the three months ended March 31, 2015, the following related activity occurred

The Company incurred $13,887 of expense payable in 35,607 common shares to New Era CPAs, an accounting firm in which Antonio Migliarese, the Company’s former Chief Financial Officer, is a partner. During the year ended December 31 2014, the Company incurred $18,300 of expense payable in 30,000 common shares to New Era CPAs. As of March 31, 2016, as a result of these transactions, 65,607 common shares were earned and issuable to New Era CPAs.
On March 1, 2016, the Company retained Brian Johnson as a consultant for an initial term of three months until May 31, 2016, and agreed to pay Mr. Johnson 10,000 shares of its restricted common stock for the three-month term payable on May 31, 2016.

Note 14. Stockholders’ Equity

 

Preferred Stock

American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding during the three month periods ended March 31, 2016 and March 31, 2015.

Common Stock 

 

American Cannabis Company, Inc. is authorized to issue 100,000,000 common shares at $0.00001 par value per share. On March 23, 2016 the Company issued 833,333 common shares to a shareholder as consideration for a stock purchase that previously closed in the first quarter of 2015.

Note 15. Subsequent Events

 

As of April 11th, 2016, the maturity date on this note was renegotiated to April 24th, 2018. On April 12, 2016, the Company received notice of a partial conversion of this note in the amount of $58,000 that was converted into 725,000 shares of common stock at a price of $0.08 per share. On May 6, 2016, the Company received notice for the conversion of the balance of the note in the amount of $13,500 that was converted into 168,750 shares of common stock at a price of $0.08 per share. Based on this conversion, as of March 31, 2016, the balance of $69,250 is reflected as a current liability.

 ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The statements contained in this report that are not statements of historical fact, including without limitation, statements containing the words “believes,” “expects,” “anticipates” and similar words, constitute forward-looking statements that are subject to a number of risks and uncertainties. From time to time we may make other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to an inherent risk that actual results may materially differ as a result of many factors, including the risks discussed from time to time in this report, including the risks described under “Risk Factors” in any filings we have made with the SEC.

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, we evaluate these estimates, including those related to useful lives of real estate assets, cost reimbursement income, bad debts, impairment, net lease intangibles, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. There can be no assurance that actual results will not differ from those estimates.

 

Background

American Cannabis Company, Inc. and subsidiary company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”, “we”, “us”, or “our”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and manage a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. We are a publicly listed company quoted on the OTCQB under the symbol “AMMJ”.

We were incorporated in the State of Delaware on September 24, 2001 under the name Naturewell, Inc. to develop and market clinical diagnostic products using immunology and molecular biologic technologies.

On March 13, 2013, Naturewell, Inc. completed a merger transaction whereby it acquired 100% of the issued and outstanding share capital of Brazil Interactive Media, Inc. (“BIMI”), which operated as a Brazilian interactive television company and television production company through its wholly owned Brazilian subsidiary company, EsoTV Brasil Promoção Publicidade Licenciamento e Comércio Ltda. (“EsoTV”). Naturewell’s Articles of Incorporation were amended to reflect a new name: Brazil Interactive Media, Inc.

On May 15, 2014, BIMI entered into a merger agreement (“the Merger Agreement”) to acquire 100% of the issued and outstanding American Cannabis Consulting while simultaneously disposing of 100% of the issued share capital EsoTV (“the Separation Agreement”). Both the merger with American Cannabis Consulting and disposal of EsoTV were completed on September 29, 2014. BIMI subsequently amended its Articles of Incorporation to change its name to American Cannabis Company, Inc.. On October 10, 2014, American Cannabis Company, Inc changed its stock symbol from BIMI to AMMJ.

The foregoing descriptions of the Merger Agreement and Separation Agreement do not purport to be complete and are qualified in their entirety by the terms of such agreements, which are filed as exhibits to the Current Report on Form 8-K filed by the Company with the U.S. Securities and Exchange Commission (“SEC”) on October 3, 2014.

Immediately following the completion of the Merger Agreement, former shareholders of American Cannabis Consulting owned 31,710,628 shares of American Cannabis Company, Inc.’s common stock representing 78.4% of American Cannabis Company, Inc.’s issued and outstanding share capital. Accordingly, American Cannabis Consulting was deemed to have been the accounting acquirer in a Reverse Merger which resulted in a recapitalization of the Company. Consequently, the Company’s consolidated financial statements reflect the results of American Cannabis Consulting since Inception (March 5, 2013) and of American Cannabis Company, Inc. (formerly BIMI) since September 29, 2014.

  

Results of Operations 

Three months ended March 31, 2016 compared to three months ended March 31, 2015

 

The following table presents our consolidated operating results for the three months ended March 31, 2016 compared to the three months ended March 31, 2015:

Three Months Three Months
Ended Ended
March 31, % of March 31, % of
2016 Revenues 2015 Revenues $ Change
Revenues
Consulting services $ 247,610 45.8 195,570 44.1 $ 52,040
Products and equipment 292,794 54.2 248,097 55.9 44,697
Total revenues 540,404 100.0 443,667 100.0 96,737
Costs of revenues
Cost of consulting services 48,522 9.0 100,892 22.7 (52,370 )
Cost of products and equipment 235,009 43.5 225,651 50.9 9,358
Total costs of revenues 283,531 52.5 326,543 73.6 (43,011 )
Gross profit 256,873 47.5 117,124 26.4 139,747
Operating expenses
General and administrative 223,487 41.4 214,499 48.3 144,404
Investor relations 17,175 3.2 131,416 29.6 (114,241 )
Selling and marketing 20,815 3.9 94,305 21.3 (73,490 )
Research and development —  —   30,372 6.8 (30,372 )
Total operating expenses 261,477 48.4 335,176 75.5 (73,699 )
Income (loss) from operations (4,604) (0.9 ) (218,052 ) (49.1 ) 213,448
Other income (expense)
Interest expense, net (8,953) (1.7 ) (8,786 ) (2.0 ) (167 )
Total other income (expense) (8,953) (1.7 ) (8,786 ) (2.0 ) (167 )
Net income (loss) before income taxes $ (13,557) (2.5 ) $ (226,838 ) (51.1 ) $ 213,281
Income tax expense (benefit) —   —   —   —  
Net income (loss) $ (13,557) (2.5 ) $ (226,838 ) (51.1 ) $ 213,281

Revenues

Total revenues were $540,404 for the three months ended March 31, 2016, compared to $443,667 for the three months ended March 31, 2015, an increase of $96,737. This increase was primarily due to the further establishment of our products and equipment offerings and growth in our client base and volume of operations as our business has matured following commencement of business operations in April 2013. For the three months ended March 31, 2016, consulting services revenue were $247,610, or 45.8% of total revenue, compared to $195,570, or 44.1% of total revenues for the three months ended March 31, 2015. For the three months ended March 31, 2016, products and equipment revenue were $292,794, or 54.2% of total revenues, compared to $248,097, or 55.9% of total revenues for the three months ended March 31, 2015.

Costs of Revenues 

Costs of revenues primarily consist of labor, travel, and other costs directly attributable to providing services or products. During the three months ended March 31, 2016, our total costs of revenues were $283,531, or 52.5% of total revenues. This compares to total costs of revenues for the three months ended March 31, 2015 of $326,543, or 73.6% of total revenues. The decrease in costs of revenues of $43,012 was primarily due to the increase in sales volume discussed above and a reduction in our internal infrastructure development. For the three months ended March 31, 2016, consulting-related costs were $48,522, or 9.0% of total revenue, as compared to costs of $100,892, or 50.9% of revenue for the three months ended March 31, 2015. Costs associated with products and equipment were $235,009, or 43.5% of total revenue for the three months ended March 31, 2016 as compared to $225,651, or 50.9% of total revenue for the three months ended March 31, 2015. As a percentage of revenues, the decreases were primarily due to higher sales volume during the three months ended March 31, 2016, as certain primarily-fixed costs such as labor made up a comparably smaller percentage of revenues.

Gross Profit

Total gross profit was $256,873 for the three months ended March 31, 2016, comprised of consulting services gross profit of $199,088 and products and equipment gross profit of $57,785. This compares to total gross profit of $117,124 for the three months ended March 31, 2015, comprised of consulting services gross profit of $94,678 and products and equipment gross profit of $22,446. These increases of $104,410 for consulting services gross profit and $35,339 for products and equipment gross profit were primarily due to growth in our client base and volume of operations and further establishment of our products and equipment offerings. As a percentage of total revenues, gross profit was 47.5% for the three months ended March 31, 2016 and 26.4% for the three months ended March 31, 2015. This increase was primarily due to higher sales volume during the three months ended March 31, 2016.

Operating Expenses

Total operating expenses were $261,477, or 48.4% of total revenues for the three months ended March 31, 2016, compared to $335,176, or 75.5% of total revenues for the three months ended March 31, 2016. This decrease was primarily due to a decrease in investor relations expenses as the company is currently utilizing internal resources for this function instead of outside sources; also the company has not to invest in research and development projects during the three months ended March 31, 2016. Also the company has reduced selling and marketing efforts due to achieving a stronger brand recognition in the market place during 2016, which has resulted in less investment in trade shows and conferences expenses during 2016 as compared to 2015.

  

Other Income (Expense) 

Other income (expense) for the three months ended March 31, 2016 was expense of $8,953, which was comprised of non-cash interest expense reflecting $8,953  of convertible notes payable discount amortization during the period, partially offset by other income. Other income (expense) for the three months ended March 31, 2015 of $8,786 of expense was comprised of interest expense related to a short-term note payable we held during that period.

Income Tax Expense (Benefit)

Although our tax status changed from a non-taxable pass-through entity (S-Corporation) to a taxable entity (C-Corporation) during the year ended December 31, 2014, due to cumulative losses since we became a C-Corporation, we recorded a valuation allowance against our related deferred tax asset which netted our deferred tax asset and benefit for income taxes to zero for the three months ended March 31 2016. We were an S-Corporation throughout the three months ended March 31, 2014, and accordingly, no provision or benefit for income taxes was applicable.

Net Income (Loss)

As a result of the factors discussed above, net income (expense) for the three months ended March 31, 2016 was net loss of $13,557, or 2.5% of total revenues for the period, as compared to a net loss of $226,838, or 51.1% of total revenues for the three months ended March 31, 2015.

Liquidity and Capital Resources

As of March 31, 2016, our primary internal sources of liquidity was our working capital, which included cash and cash equivalents of $277,453 and accounts receivable of $27,267. We also have the ability to raise additional capital as needed through external equity financing transactions. For the three months ended March 31, 2016, primarily as a result of non-cash expenses, the Company’s operating cash flows were a use of $276,522 due to  a net loss of $13,557. Additionally, considering that our fixed overhead costs are low, we have the ability to issue stock to compensate employees and management, and the level of future revenue we expect to generate from executed client contracts, we believe our liquidity and capital resources to be adequate to fund our operational and general and administrative expenses for at least the next 12 months without needing to raise additional debt or equity funding. . There is no guarantee we will have the ability to raise additional capital as needed through external equity financing transactions if required.

Operating Activities

Net cash used in by operating activities for the three months ended March 31, 2016 was a use of $276,522, consisting of net loss of $13,557, decreases in accounts payable of $163,555 due to inventory product purchases, a decrease in advances from clients $72,883 which related to recognition of revenues from advances received during 2015 and inventory of $33,960 based on product purchases. Net cash used in operating activities for the three months ended March 31, 2015 was $32,362 consisting of a loss of $226,838 which was offset by net non-cash adjustments of $108,212 related to employee and professional service stock-based compensation, amortization of discount on convertible notes payable of $8,803 and a net source of cash of $182,026 due to increases in accounts payable and other current liabilities.

Investing Activities

For the three months ended March 31, 2016 and 2015, Investing activities were a use of cash of $1,805 and $11,250, respectively. This was due to purchases of office furniture and computer equipment during the three months ended March 31, 2016 and 2015, respectively.

Financing Activities

For the three months ended March 31, 2016, the net cash from financing activities was $0, while net cash provided by financing activities for the three months ended March 31, 2015 was $250,000 reflecting the sale of 833,333 shares of common stock to an investor during the period.

Off Balance Sheet Arrangements

As of March 31, 2016 and December 31, 2015, we did not have any off balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Non-GAAP Financial Measures

 

We use Adjusted EBITA, a non-GAAP metric, to monitor our overall business performance. We define Adjusted EBITA as net income (loss) before interest expense, net, provision for (benefit from) income taxes, stock-based compensation and certain non-recurring expenses, which to date have been limited to costs associated with the Reverse Merger. We believe that such adjustments to arrive at Adjusted EBITA provides us with a more comparable measure for managing our business. We also believe that it is a useful measure for securities analysts, investors, and other interested parties in the evaluation of our company.

A reconciliation of net income (loss) to Adjusted EBITA is provided below.

 

Three Months Ended Three Months Ended
March 31, 2016 March 31, 2015
(Unaudited) (Unaudited)
Adjusted EBITA reconciliation:
Net income (loss) (13,557 ) (226,838 )
Stock-based compensation to employees —   43,271
Stock-based compensation to service providers $ 1,100 63,839
Interest expense, net 8,953 8,786
Tax expense (benefit) —   —  
Adjusted EBITA $ (3,504 ) $ (110,947 )

 

ITEM 3. QUANTITATIVE & QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

ITEM 4. CONTROLS AND PROCEDURES

 

Management of the Company is responsible for maintaining disclosure controls and procedures that are designed to ensure that financial information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the timeframes specified in the Securities and Exchange Commission’s rules and forms, consistent with Items 307 and 308 of Regulation S-K.

 

In addition, the disclosure controls and procedures must ensure that such financial information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial and other required disclosures.

 

As of March 31, 2016, an evaluation of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13(a)-15(e) and 15(d)-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) was carried out under the supervision and with the participation of our Chief Executive Officer, Chief Financial Officer, and other persons carrying out similar functions for the Company. Based on the evaluation of the Company’s disclosure controls and procedures, the Company concluded that during the period covered by this report, such disclosure controls and procedures were not effective.

 

The Company continues to employ and refine a structure in which critical accounting policies, issues and estimates are identified, and together with other complex areas, are subject to multiple reviews by accounting personnel. In addition, the Company evaluates and assesses its internal controls and procedures regarding its financial reporting, utilizing standards incorporating applicable portions of the Public Company Accounting Oversight Board’s 2009 Guidance for Smaller Public Companies in Auditing Internal Controls Over Financial Reporting as necessary and on an on-going basis.

 

Because of its inherent limitations, internal control over financial reporting cannot provide absolute assurance of the prevention or detection of misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Controls

  

The Company has no reportable changes to its internal controls over financial reporting for the period covered by this report. 

The Company will continually enhance and test its internal controls over financial reporting on a continuing basis. Additionally, the Company’s management, under the control of its Chief Executive Officer and Chief Financial Officer, will increase its review of its disclosure controls and procedures on an ongoing basis. Finally, the Company plans to designate, in conjunction with its Chief Financial Officer, individuals responsible for identifying reportable developments and the process for resolving compliance issues related to them. The Company believes these actions will focus necessary attention and resources in its internal accounting functions.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

On January 20, 2016, we were named as a defendant in a civil suit entitled: Anthony Baroud vs. Hollister & Blacksmith, Inc., dba American Cannabis Company filed in the Circuit Court of Cook County, Illinois. The lawsuit seeks damages of $100,000 related to an employment contract. The Company filed a motion to compel contractual arbitration that has yet to be ruled on by the Court.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item. 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

No transactions meeting the reporting requirements of this item occurred during the periods covered by this report.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

No senior securities were issued and outstanding during the three months ended March 31, 2016 or 2015.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

This list is intended to constitute the exhibit index.

 

31.1 Certification of Principal Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 Certification of Principal Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS XBRL Instance Document*
101.SCH XBRL Taxonomy Extension Schema Document*
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB XBRL Taxonomy Extension Label Linkbase Document*
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document*

 

*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities and Exchange Act of 1934, and otherwise are not subject to liability under those sections.

 SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

American Cannabis Company, Inc.
Date: May 17, 2016 By: /s/ Corey Hollister
Corey Hollister,
Chief Executive Officer
(Principal Executive Officer)
Date: May 17, 2016 By: /s/ Jesus Quintero
Jesus Quintero,
Chief Financial Officer
(Principal Financial Officer)